Comparison

Bortezomib

Item no. CAPS-C07434-10mM/1mL
Manufacturer Capsid Biotechnology
CASRN 179324-69-7
Amount 10 mM/1 ml
Quantity options 100 mg 10 mM/1 ml 1 g 25 mg 5 mg
Category
Type Chemicals
Specific against other
Smiles B(C(CC(C)C)NC(=O)C(CC1=CC=CC=C1)NC(=O)C2=NC=CN=C2)(O)O
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias LDP-341,MLM341,NSC 681239,PS-341,BTZ
Available
Storage Conditions
3 years -20°C (in the dark) powder1 year -80°C (in the dark) in solvent
Small Target
Proteasome
Big Target
Proteases
Information
Bortezomib is a potent 20S proteasome inhibitor with Ki of 0.6 nM. It exhibits favorable selectivity towards tumor cells over normal cells. Bortezomib (PS-341) inhibits NF-κB and induces ERK phosphorylation to suppress cathepsin B and inhibit the catalytic process of autophagy in ovarian cancer and other solid tumors.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mM/1 ml
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close